Trelegy ellipta 100-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FRX17
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,088
Award facts
- Contract value 100% obligated
- $6,088.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,088.32 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, and employs firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
The SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This prime contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related supplies across multiple therapeutic domains, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order reflects AmerisourceBergen's ongoing role as a major pharmaceutical distributor for federal medical procurement, demonstrating the company's capability to fulfill competitive federal requirements for military and veteran healthcare supply needs.
Quick answers
Who was awarded contract SPE2DB25FRX17?
SPE2DB25FRX17 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FRX17 worth?
The government has obligated $6,088 on SPE2DB25FRX17.
Is contract SPE2DB25FRX17 an order under another contract?
Yes. SPE2DB25FRX17 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRX17 competed?
The extent of competition for SPE2DB25FRX17 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award